Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The repeatable battery for the assessment of neuropsychological status (RBANS) and substance use disorders: a systematic review.
Subst Abuse Treat Prev Policy
March 2025
Division of Mental Health and Addiction, Vestfold Hospital Trust, 2168, Tønsberg, Vestfold, 3103, Norway.
Background: Cognitive deficits are prevalent among substance use disorder (SUD) patients and affect treatment retention and outcome. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a well-researched instrument in diverse patient groups and has the potential to serve as an effective and accurate method for identifying cognitive impairment in SUD patients. This systematic review examines the RBANS' ability to detect cognitive impairment in SUD patients.
View Article and Find Full Text PDFMaternal dietary DHA and EPA supplementation ameliorates adverse cardiac outcomes in THC-exposed rat offspring.
Sci Rep
March 2025
Department of Physiology and Pharmacology, Western University, London, Canada.
Cannabis use in pregnancy is associated with low birthweight outcomes. Recent preclinical data suggests that maternal Δ9-tetrahydrocannabinol (THC) exposure leads to decreases in birthweight followed by early cardiac deficits in offspring. Currently, no studies have explored an intervention for these maternal THC-induced deficits.
View Article and Find Full Text PDFNo Abstract Available.
View Article and Find Full Text PDFCannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients.
Int J Drug Policy
March 2025
New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA; Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032, USA. Electronic address:
Study Objectives: Rates of cannabis use disorder (CUD) appear to be increasing nationally, with increases greater in states that legalized cannabis use. However, as legalization has progressed and stigma declined, some of these apparent increases could be due to greater willingness of survey respondents and patients to acknowledge cannabis involvement. Biological indicators of cannabis use overcome some concerns about trends denoted by self-report data whose validity is potentially changing over time.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!